Antiproliferative effects of sapacitabine (CYC682), a novel 2′-deoxycytidine-derivative, in human cancer cells

This study assessed the antiproliferative activity of sapacitabine (CYC682, CS-682) in a panel of 10 human cancer cell lines with varying degrees of resistance or sensitivity to the commonly used nucleoside analogues ara-C and gemcitabine. Growth inhibition studies using sapacitabine and CNDAC were...

Descripción completa

Detalles Bibliográficos
Autores principales: Serova, M, Galmarini, C M, Ghoul, A, Benhadji, K, Green, S R, Chiao, J, Faivre, S, Cvitkovic, E, Le Tourneau, C, Calvo, F, Raymond, E
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2007
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360357/
https://www.ncbi.nlm.nih.gov/pubmed/17637678
http://dx.doi.org/10.1038/sj.bjc.6603896

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360357/
https://www.ncbi.nlm.nih.gov/pubmed/17637678
http://dx.doi.org/10.1038/sj.bjc.6603896

Ejemplares similares